1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis
    Meeting Abstract

    Kristeleit, R.; Swisher, E.; Oza, A.; Coleman, R. L.; Scott, C.; Konecny, G.; Tinker, A.; O'Malley, D. M.; Brenton, J.; Bell-Mcguinn, K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma
    Meeting Abstract

    Jordan, E.; Won, H.; Toubaji, A.; Bagrodia, A.; Desai, N.; Bajorin, D.; Rosenberg, J.; Bochner, B.; Kim, W.; Berger, M.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
    Meeting Abstract

    Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    McDermott, D. F.; Infante, J. R.; Chowdhury, S.; Voss, M. H.; Motzer, R. J.; Perini, R. F.; Morosky, A.; Zheng, F. F.; White, B. C.; Wang, Q.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis
    Meeting Abstract

    Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
    Meeting Abstract

    Harshman, L.; Werner, L.; Wong, Y. N.; Yu, E.; Alva, A.; Crabb, S.; Powles, T.; Rosenberg, J.; Baniel, J.; Vaishampayan, U.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Predicting venous thromboembolism (VTE) in metastatic urothelial tract tumors (UTT)
    Meeting Abstract

    Ramos, J.; Casey, M.; Bamias, A.; De Giorgi, U.; Bellmunt, J.; Harshman, L.; Ladoire, S.; Wong, Y. N.; Alva, A.; Necchi, A.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A non-invasive urine exosome gene expression assay (Exo106) accurately predicts pathologic stage and grade in the prostatectomy specimen
    Meeting Abstract

    Donovan, M.; Eastham, J.; Patel, V.; McKiernan, J.; Noerholm, M.; Belzer, S.; Bentink, S.; O'Neill, V.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Baseline characteristics, number of radium-223 (Ra-223) injections, and overall survival (OS) in US Expanded Access Program (EAP) and ALSYMPCA
    Meeting Abstract

    Sartor, O.; Coleman, R. E.; Morris, M. J.; Nilsson, S.; Shore, N.; Sweeney, C.; Vogelzang, N. J.; Petrenciuc, O.; Gratt, J.; Parker, C.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Early onset colorectal cancer - Does the difference lie in epigenetics?
    Meeting Abstract

    Ben-Aharon, I.; Pelossof, R.; Elkabets, M.; Battaglin, F.; Goodman, K.; Yaeger, R.; Saltz, L.; Schultz, N.; Solit, D.; Garcia-Aguilar, J.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save